Dr. Kumar on Ixazomib Combo for Multiple Myeloma Treatment
December 24th 2014Shaji Kumar, MD, professor of medicine at the Mayo Clinic, discusses the use of the proteasome inhibitor ixazomib in combination with lenalidomide (Revlimid) and dexamethasone for the treatment of newly diagnosed multiple myeloma.
Read More
Dr. Kumar on the Design of a Phase II Trial of MLN9708
January 15th 2014Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, describes the design of a phase II trial looking at the single-agent activity of the proteasome inhibitor MLN9708 for the treatment of patients with multiple myeloma.
Read More